Literature DB >> 16235065

Functional analysis of novel KCNQ2 and KCNQ3 gene variants found in a large pedigree with benign familial neonatal convulsions (BFNC).

Maria T Bassi1, Umberto Balottin, Chris Panzeri, Paolo Piccinelli, Pasqualina Castaldo, Vincenzo Barrese, Maria V Soldovieri, Francesco Miceli, Maria Colombo, Nereo Bresolin, Renato Borgatti, Maurizio Taglialatela.   

Abstract

Benign familial neonatal convulsion (BFNC) is a rare autosomal dominant disorder caused by mutations in KCNQ2 and KCNQ3, two genes encoding for potassium channel subunits. A large family with nine members affected by BFNC is described in the present study. All affected members of this family carry a novel deletion/insertion mutation in the KCNQ2 gene (c.761_770del10insA), which determines a premature truncation of the protein. In addition, in the family of the proposita's father, a novel sequence variant (c.2687A>G) in KCNQ3 leading to the p.N821S amino acid change was detected. When heterologously expressed in Chinese hamster ovary cells, KCNQ2 subunits carrying the mutation failed to form functional potassium channels in homomeric configuration and did not affect channels formed by KCNQ2 and/or KCNQ3 subunits. On the other hand, homomeric and heteromeric potassium channels formed by KCNQ3 subunits carrying the p.N821S variant were indistinguishable from those formed by wild-type KCNQ3 subunits. Finally, the current density of the cells mimicking the double heterozygotic condition for both KCNQ2 and KCNQ3 alleles of the proband was decreased by approximately 25% when compared to cells expressing only wild-type alleles. Collectively, these results suggest that, in the family investigated, the KCNQ2 mutation is responsible for the BFNC phenotype, possibly because of haplo-insufficiency, whereas the KCNQ3 variant is functionally silent, a result compatible with its lack of segregation with the BFNC phenotype.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16235065     DOI: 10.1007/s10048-005-0012-2

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  24 in total

1.  A carboxy-terminal domain determines the subunit specificity of KCNQ K+ channel assembly.

Authors:  Michael Schwake; Thomas J Jentsch; Thomas Friedrich
Journal:  EMBO Rep       Date:  2003-01       Impact factor: 8.807

2.  KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel.

Authors:  H S Wang; Z Pan; W Shi; B S Brown; R S Wymore; I S Cohen; J E Dixon; D McKinnon
Journal:  Science       Date:  1998-12-04       Impact factor: 47.728

3.  The identification and characterization of a noncontinuous calmodulin-binding site in noninactivating voltage-dependent KCNQ potassium channels.

Authors:  Eva Yus-Najera; Irene Santana-Castro; Alvaro Villarroel
Journal:  J Biol Chem       Date:  2002-05-24       Impact factor: 5.157

4.  Myokymia and neonatal epilepsy caused by a mutation in the voltage sensor of the KCNQ2 K+ channel.

Authors:  K Dedek; B Kunath; C Kananura; U Reuner; T J Jentsch; O K Steinlein
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-25       Impact factor: 11.205

Review 5.  Potassium channels: molecular defects, diseases, and therapeutic opportunities.

Authors:  C C Shieh; M Coghlan; J P Sullivan; M Gopalakrishnan
Journal:  Pharmacol Rev       Date:  2000-12       Impact factor: 25.468

6.  Moderate loss of function of cyclic-AMP-modulated KCNQ2/KCNQ3 K+ channels causes epilepsy.

Authors:  B C Schroeder; C Kubisch; V Stein; T J Jentsch
Journal:  Nature       Date:  1998-12-17       Impact factor: 49.962

7.  Neonatal convulsions and epileptic encephalopathy in an Italian family with a missense mutation in the fifth transmembrane region of KCNQ2.

Authors:  Karin Dedek; Lucia Fusco; Nicole Teloy; Ortrud K Steinlein
Journal:  Epilepsy Res       Date:  2003-04       Impact factor: 3.045

8.  KCNQ2 and KCNQ3 potassium channel genes in benign familial neonatal convulsions: expansion of the functional and mutation spectrum.

Authors:  Nanda A Singh; Peter Westenskow; Carole Charlier; Chris Pappas; Jonathan Leslie; Jessica Dillon; V Elving Anderson; Michael C Sanguinetti; Mark F Leppert
Journal:  Brain       Date:  2003-10-08       Impact factor: 13.501

9.  Surface expression and single channel properties of KCNQ2/KCNQ3, M-type K+ channels involved in epilepsy.

Authors:  M Schwake; M Pusch; T Kharkovets; T J Jentsch
Journal:  J Biol Chem       Date:  2000-05-05       Impact factor: 5.157

10.  A novel mutation in KCNQ2 associated with BFNC, drug resistant epilepsy, and mental retardation.

Authors:  R Borgatti; C Zucca; A Cavallini; M Ferrario; C Panzeri; P Castaldo; M V Soldovieri; C Baschirotto; N Bresolin; B Dalla Bernardina; M Taglialatela; M T Bassi
Journal:  Neurology       Date:  2004-07-13       Impact factor: 9.910

View more
  9 in total

1.  Alternative splicing of Na(V)1.7 exon 5 increases the impact of the painful PEPD mutant channel I1461T.

Authors:  Brian W Jarecki; Patrick L Sheets; Yucheng Xiao; James O Jackson; Theodore R Cummins
Journal:  Channels (Austin)       Date:  2009-07-23       Impact factor: 2.581

Review 2.  Ion Channel Genes and Epilepsy: Functional Alteration, Pathogenic Potential, and Mechanism of Epilepsy.

Authors:  Feng Wei; Li-Min Yan; Tao Su; Na He; Zhi-Jian Lin; Jie Wang; Yi-Wu Shi; Yong-Hong Yi; Wei-Ping Liao
Journal:  Neurosci Bull       Date:  2017-05-09       Impact factor: 5.203

Review 3.  Nervous system KV7 disorders: breakdown of a subthreshold brake.

Authors:  Snezana Maljevic; Thomas V Wuttke; Holger Lerche
Journal:  J Physiol       Date:  2008-01-31       Impact factor: 5.182

4.  Altered KCNQ3 potassium channel function caused by the W309R pore-helix mutation found in human epilepsy.

Authors:  Akira Uehara; Yuki Nakamura; Takao Shioya; Shinichi Hirose; Midori Yasukochi; Kiyoko Uehara
Journal:  J Membr Biol       Date:  2008-04-20       Impact factor: 1.843

Review 5.  Channelopathies in idiopathic epilepsy.

Authors:  Sarah E Heron; Ingrid E Scheffer; Samuel F Berkovic; Leanne M Dibbens; John C Mulley
Journal:  Neurotherapeutics       Date:  2007-04       Impact factor: 7.620

6.  Retigabine, a Kv7.2/Kv7.3-Channel Opener, Attenuates Drug-Induced Seizures in Knock-In Mice Harboring Kcnq2 Mutations.

Authors:  Yukiko Ihara; Yuko Tomonoh; Masanobu Deshimaru; Bo Zhang; Taku Uchida; Atsushi Ishii; Shinichi Hirose
Journal:  PLoS One       Date:  2016-02-24       Impact factor: 3.240

7.  Genetic regulation of gene expression in the epileptic human hippocampus.

Authors:  Nasir Mirza; Richard Appleton; Sasha Burn; Daniel du Plessis; Roderick Duncan; Jibril Osman Farah; Bjarke Feenstra; Anders Hviid; Vivek Josan; Rajiv Mohanraj; Arif Shukralla; Graeme J Sills; Anthony G Marson; Munir Pirmohamed
Journal:  Hum Mol Genet       Date:  2017-05-01       Impact factor: 6.150

8.  Familial neonatal seizures caused by the Kv7.3 selectivity filter mutation T313I.

Authors:  Jasmine Maghera; Jingru Li; Shawn M Lamothe; Marvin Braun; Juan P Appendino; P Y Billie Au; Harley T Kurata
Journal:  Epilepsia Open       Date:  2020-10-17

9.  Unraveling synonymous and deep intronic variants causing aberrant splicing in two genetically undiagnosed epilepsy families.

Authors:  Qiang Li; Yiting Wang; Yijun Pan; Jia Wang; Weishi Yu; Xiaodong Wang
Journal:  BMC Med Genomics       Date:  2021-06-09       Impact factor: 3.063

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.